KHOA VO: Open Payments
NPI 1225094931 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,254 in 161 payments from 20 companies in 2025. Trend: 2023 $3,050 · 2024 $3,279 · 2025 $3,254
Food & beverage: $3,254
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $440 |
| ABBVIE INC. | 24 | $326 |
| Otsuka America Pharmaceutical, Inc. | 10 | $305 |
| Vanda Pharmaceuticals Inc. | 14 | $287 |
| Almatica Pharma LLC | 12 | $246 |
| Supernus Pharmaceuticals, Inc. | 10 | $226 |
| E.R. Squibb & Sons, L.L.C. | 9 | $214 |
| Lundbeck LLC | 10 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $166 |
| Noven Therapeutics, LLC | 9 | $154 |
Products named: REXULTI, Auvelity, VRAYLAR, HETLIOZ, LOREEV XR, Qelbree, COBENFY, CAPLYTA.
Industry payments across SC — which companies pay providers there.
